Comparative Pharmacology
Head-to-head clinical analysis: TEPANIL versus TEPANIL TEN TAB.
Peer-Reviewed Evidence
Head-to-head clinical analysis: TEPANIL versus TEPANIL TEN TAB.
TEPANIL vs TEPANIL TEN-TAB
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
TEPANIL (diethylpropion) is a sympathomimetic amine that acts as a norepinephrine reuptake inhibitor in the hypothalamus, increasing norepinephrine levels in the synaptic cleft, which stimulates beta-2 adrenergic receptors, leading to appetite suppression.
TEPANIL TEN-TAB (diethylpropion hydrochloride controlled-release) is a sympathomimetic amine anorectic agent. It acts primarily on the central nervous system to suppress appetite, likely via stimulation of the hypothalamus to release norepinephrine and dopamine, leading to decreased food intake. The exact molecular mechanism involves inhibition of norepinephrine and dopamine reuptake in the synaptic cleft, increasing their concentrations in the central nervous system.
25 mg orally three times daily, 1 hour before meals, or 75 mg extended-release orally once daily in the morning.
25 mg orally three times daily, 1 hour before meals; for sustained-release, 75 mg orally once daily in the morning.
None Documented
None Documented
4-6 hours; clinical context: requires multiple daily dosing for sustained anorectic effect
Terminal elimination half-life is 4-6 hours. Clinical context: Steady state is achieved within 1-2 days.
Renal: 90% (as metabolites and unchanged drug), Fecal: <10%
Renal excretion accounts for 60-80% of the dose. Biliary/fecal elimination is approximately 10-20%.
Category C
Category C
Sympathomimetic anorectic
Sympathomimetic anorectic